Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TRVI | AMGN | VRTX | REGN | BMY |
| Company | Trevi Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 2.94 | 301.75 | 406.42 | 967.88 | 43.98 |
| High | 3.02 | 302.91 | 415.67 | 967.88 | 44.26 |
| Low | 2.88 | 298.51 | 394.03 | 957.10 | 43.88 |
| Last | 2.93 | 299.44 | 409.10 | 964.94 | 43.89 |
| Change | -0.01 | -0.04 | +6.60 | +6.30 | -0.01 |
| % Change | -0.34% | -0.01% | +1.64% | +0.66% | -0.02% |
| Volume | 43,864 | 1,491,805 | 1,178,738 | 204,072 | 6,755,632 |
| 20-Day Average Volume | 135,040 | 2,772,009 | 1,078,155 | 513,873 | 14,149,897 |
| Previous Close | 2.94 | 299.48 | 402.50 | 958.64 | 43.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.83 | 275.24 | 398.58 | 911.69 | 46.72 |
| 20-Day Raw Stochastic | 71.25% | 62.68% | 73.80% | 91.68% | 8.01% |
| 20-Day Relative Strength | 51.35% | 62.69% | 53.74% | 59.85% | 29.48% |
| Weighted Alpha | -13.02 | +27.64 | +17.56 | +28.95 | -36.24 |
| Today's Opinion | 56% Buy | 40% Buy | 32% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 56% Buy | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 64% Buy | 24% Sell | 24% Buy | 56% Buy | 32% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.34% since 04/30/24 | +9.33% since 04/30/24 | +4.18% since 04/30/24 | +7.80% since 04/30/24 | +0.07% since 04/30/24 |
| Low | 2.74 on 05/01/24 | 273.38 on 05/01/24 | 392.47 on 05/01/24 | 888.52 on 05/01/24 | 43.33 on 05/02/24 |
| High | 3.12 on 05/03/24 | 322.60 on 05/03/24 | 415.67 on 05/07/24 | 967.88 on 05/07/24 | 44.62 on 05/06/24 |
| 1-Month | |||||
| %Chg | -4.89% since 04/05/24 | +10.94% since 04/05/24 | +0.62% since 04/05/24 | +1.85% since 04/05/24 | -14.32% since 04/05/24 |
| Low | 2.35 on 04/17/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 3.20 on 04/09/24 | 322.60 on 05/03/24 | 415.67 on 05/07/24 | 967.88 on 05/07/24 | 51.68 on 04/09/24 |
| 3-Month | |||||
| %Chg | +98.64% since 02/07/24 | +1.22% since 02/07/24 | -2.36% since 02/07/24 | +2.31% since 02/07/24 | -9.60% since 02/07/24 |
| Low | 1.39 on 02/08/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 4.00 on 03/21/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +91.48% since 11/07/23 | +10.47% since 11/07/23 | +8.19% since 11/07/23 | +15.57% since 11/07/23 | -15.91% since 11/07/23 |
| Low | 0.97 on 11/27/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 4.00 on 03/21/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 207,079 | 160,633,888 | 104,029,752 | 105,222,248 | 88,989,688 |
| Shares Outstanding, K | 70,435 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -29,070,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,517,700,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -7,820,000 | -113,000,000 | 968,800,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 0.91 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 03/20/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.71 | 29.84 | 25.79 | 41.90 |